← Open Payments lookup

DAVID PURSELLE: Open Payments

NPI 1356384135 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$80,699 in 132 payments from 12 companies in 2025. Trend: 2023 $91,827 · 2024 $57,152 · 2025 $80,699

Consulting: $41,877Speaker / faculty: $23,817Travel & lodging: $11,827Food & beverage: $3,178
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.51$53,941
ABBVIE INC.18$12,641
Vanda Pharmaceuticals Inc.21$11,288
Neurocrine BioSciences, Inc.13$2,151
Janssen Pharmaceuticals, Inc7$181
Otsuka America Pharmaceutical, Inc.11$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$131
Lundbeck LLC1$102
Axsome Therapeutics, Inc.2$40
Tris Pharma Inc1$24

Products named: REXULTI, VRAYLAR, FANAPT, SPRAVATO, CAPLYTA, HETLIOZ, Auvelity, Dyanavel XR.

Industry payments across GA — which companies pay providers there.